Filter
715
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
368
Studies & Reports
132
Guidelines
119
Manuals
34
Strategic & Response Plan
34
Fact sheets
10
Situation Updates
9
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Kenya
31
Global
30
Nigeria
20
Ghana
20
Ethiopia
19
Uganda
19
Sierra Leone
13
Western and Central Europe
13
Nepal
12
Zambia
12
Tanzania
12
South Africa
12
Bangladesh
12
Malawi
9
Botswana
9
Liberia
8
Zimbabwe
8
Ukraine
8
Lesotho
8
Africa
8
Namibia
7
Myanmar / Burma
7
South–East Asia Region
7
Philippines
6
Rwanda
6
Latin America and the Carribbean
6
Indonesia
5
Eastern Europe
5
Eswatini/ Swaziland
4
Haiti
3
Cambodia
3
Thailand
3
East and Southern Africa
3
West and Central Africa
3
Albania
3
Tajikistan
3
Russia
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Mozambique
2
Sudan
2
Western Pacific Region
2
Asia
2
Laos
2
Moldova
2
Guinea
1
Congo, Democratic Republic of
1
USA
1
South Sudan
1
Syria
1
China
1
Benin
1
Brazil
1
Serbia
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Southern Africa
1
Uzbekistan
1
Australia
1
Vietnam
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
57
Pharmacy & Technologies
31
Public Health
29
Key Resources
18
Women & Child Health
13
Capacity Building
4
Toolboxes
Pharmacy
84
AMR
81
COVID-19
53
HIV
47
TB
37
Mental Health
34
Planetary Health
16
Ebola
14
Rapid Response
14
NTDs
13
NCDs
12
Global Health Education
11
Health Financing Toolbox
9
Conflict
5
Specific Hazards
5
Caregiver
4
Cholera
3
Natural Hazards
3
Polio
2
Disability
1
Refugee
1
Zika
1
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv
...
Principles and Target Product Criteria. Roadmap January 12, 2015
Promoting People's Health to Enhance Social-economic Development
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent
...
SOP- Quality Assurance of Malaria Diagnostic Tests
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United
...
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries